Delivery Order SPE2DR25D3103-SPE2DR26F9R47
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of KANJINTI 420 MG VIALS. The firm-fixed-price contract has a ceiling value of $14,564.76 and a completion date of May 10, 2024. AmerisourceBergen, a subsidiary of Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical worth up to $999,999,999.00 through December 2025,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $28,813.47 by the Defense Logistics Agency's Medical Supply Chain on December 8, 2025. This firm fixed-price delivery order, which is expected to be completed by December 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through competitive...
- The Defense Logistics Agency awarded a $1,599.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 4, 2025, with completion scheduled for December 5, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was made on a competitive, non-set-aside basis to the major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $22,129.36 to AmerisourceBergen Drug Corp for pharmaceutical products and supplies. This firm fixed-price delivery order, issued on November 26, 2025, with an ultimate completion date of the same date, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The award was made through competitive procedures with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a $631,451.37 firm fixed price delivery order by the Defense Logistics Agency's Medical Supply Chain on December 15, 2025, with an ultimate completion date of December 16, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at the company's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $15,484.50 by the Defense Logistics Agency's Medical Supply Chain on November 20, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order carries an ultimate...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $543,349.18 to AmerisourceBergen Drug Corp on December 18, 2025, with completion targeted for December 19, 2025. This competitive delivery order, issued under a firm fixed-price arrangement with no set-aside designation, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The award enables AmerisourceBergen to supply...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $28,312.40 by the Defense Logistics Agency's Medical Supply Chain on December 15, 2025, with an ultimate completion date of December 16, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle that extends through...
- The Defense Logistics Agency awarded a delivery order valued at $10,449.29 to AmerisourceBergen Drug Corp for pharmaceutical supplies under a firm fixed-price contract. This non-set-aside delivery order, issued on December 11, 2025, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The work will be performed at the contractor's corporate office in Conshohocken, Pennsylvania, and involves the provision of pharmaceutical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,177.85 to AmerisourceBergen Drug Corp on December 8, 2025, with completion targeted for December 9, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999.999 billion through December 2026. The award is for pharmaceutical products and...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9R47Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,595.28 to AmerisourceBergen Drug Corp for the supply of Kanjinti 420 mg vials, with a firm fixed price and no set-aside designation. The award was issued on December 19, 2025, with an ultimate completion date of December 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate office location. This delivery order represents a pediatric or adult pharmaceutical supply requirement typical of the Defense Logistics Agency's medical procurement operations supporting military and federal healthcare systems. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. AmerisourceBergen's competitive award history and substantial contract portfolio demonstrate its capability to meet federal medical procurement requirements, and the company currently serves multiple government healthcare customers including the Defense Health Agency and U.S. Coast Guard through this flexible contracting arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 12/18/25 |